ArticleBritish journal of haematology2026

Glofitamab in combination with immunochemotherapy in patients with relapsed/refractory B-cell non-Hodgkin lymphoma: Phase 1b dose-escalation study.

William Townsend et al.PubMed ↗Publisher ↗

No numbers read from the abstract.